AstraZeneca's total revenue in the first quarter increased by 19% year-on-year
芊芊551
发表于 2024-4-25 15:27:55
228
0
0
On April 25th, AstraZeneca announced its financial results for the first quarter of 2024: total revenue was $12.679 billion, a year-on-year increase of 19%; Core earnings per share were $2.06, a year-on-year increase of 13%.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- LeXin releases third quarter financial report: revenue of 3.66 billion yuan, profit increased by 33.2% month on month
- Hesai Technology's Q3 revenue increased by 21.1% year-on-year
- Shangde Institution's third quarter revenue and profit continue to decline, and fancy marketing is unable to turn things around
- Zhiwen Group's net revenue for Q3 2024 was 2.6747 billion yuan, with a net profit of 493.3 million yuan
- Oracle's quarterly revenue and profit both increased
- The ninth one! Broadcom joins trillion dollar club, AI revenue doubles
- Pfizer expects revenue of $61 billion to $64 billion in 2025, with an estimated $63.23 billion
- Micron Technology's revenue outlook falls short of analysts' expectations, causing its stock price to plummet by approximately 18% after market hours
- Micron Technology's revenue outlook falls short of analysts' expectations, causing its stock price to plummet by approximately 18% after market hours
